Recent News
$10 Million Invokana Lawsuit Seeks Compensation for DKA, Kidney Damage
A Texas woman has filed a $10 million Invokana lawsuit for diabetic ketoacidosis (DKA) and kidney damage allegedly related to her use of the Type 2 diabetes medication. According to the complaint, which is currently pending in the U.S. District … Continue reading
Taxotere Lawsuit Claims Chemo Treatment Caused Permanent Baldness
Taxotere lawsuits involving the chemotherapy treatment’s alleged association with permanent hair loss are beginning to mount in courts around the U.S. One of the first such cases was filed earlier this year by an Ohio woman who has accused Sanofi-Aventis … Continue reading
Nexium Kidney Disease Concern Raised in Recent Study
A recent study has raised new concerns about the safety of Nexium and other Proton Pump Inhibitors (PPIs). The paper, which was published in the January 11th issue of JAMA: Internal Medicine, suggested that patients who use these popular heart … Continue reading
Talcum Powder Whistleblower Refused $1.3 Million Settlement From Johnson & Johnson
It’s not easy to turn down $1.3 million. But that’s exactly what Deane Berg did when Johnson & Johnson offered to settle her talcum powder lawsuit on the condition that it remain confidential. “Talcum Powder Products Should Be Withdrawn from … Continue reading
FDA Orders New Essure Warnings, As Critics Press for Recall
Federal regulators have ordered new label warnings for the Essure birth control implant, a system of permanent contraception that has been the subject of thousands of patient complaints. For many women, however, the new warnings do not go far enough, … Continue reading
Onglyza, Other DPP-4 Inhibitors May Raise Risk For Acute Pancreatitis
A recent study is helping to fuel safety concerns surrounding Onglyza. The research, which was presented this past December at the World Diabetes Congress 2015, suggested that patients using Onglyza and other DPP-4 inhibitor medications might face a small, but … Continue reading
Talcum Powder Lawsuit Jury Orders Johnson & Johnson to Pay $72 Million in Ovarian Cancer Case
The family of an Alabama woman has been awarded $72 million, after a St. Louis jury found that Johnson & Johnson’s talc products caused her ovarian cancer. The verdict marks the first time a jury has ordered the company to … Continue reading
Invokana News: EMA Looks to Reduce Risk of Ketoacidosis Among SGLT2 Inhibitor Users
Regulators in Europe have issued new recommendations aimed at reducing the occurrence of ketoacidosis among patients who take Invokana and other SGLT2 inhibitor Type 2 diabetes medications. The release of the recommendations follows a months-long review of the SGLT2 class … Continue reading
$13.5 Million Awarded in Pennsylvania Transvaginal Mesh Trial
A Philadelphia jury has ordered Ethicon, Inc. to pay $13.5 million to a transvaginal mesh plaintiff who suffered serious complications related to the erosion of the company’s TVT midurethral sling. This marked the second loss for the Johnson & Johnson … Continue reading
Follow Us
